Committed To Fighting Cancer

Lucence Diagnostics was founded by Dr. Min-Han Tan in 2016 to solve the most complex diagnostic problems in medicine through the most innovative technology possible. A world leader in medicine, Dr. Tan’s research has spanned diverse fields of clinical medicine, human genetics and medical data analytics to regularly rewrite orthodoxy. He is recognized internationally for his landmark discovery of the circulating tumor-endothelial cell clusters in the blood of cancer patients, which overturned a 50-year scientific dogma and led to a new way of looking at cancer.

Infused with the same DNA of restless and relentless innovation, Lucence is focused on delivering advanced cancer
diagnostic tests to improve cancer care. Our team consists of physicians, scientists, technologists, geneticists, bioinformaticians and data analysts who are committed to fighting cancer.

Lucence Diagnostics was founded by Dr. Tan Min-Han in 2016 to solve the most complex diagnostic problems in medicine through the most innovative technology design possible. A world leader in medicine, Dr. Tan’s research has spanned diverse fields of clinical medicine, human genetics and medical data analytics to regularly rewrite orthodoxy. He is recognized internationally for his landmark discovery of the circulating tumor-endothelial cell clusters in the blood of cancer patients, which overturned a 50-year scientific dogma and led to a new way of looking at cancer.

 

Infused with the same DNA of restless and relentless innovation, Lucence is focused on delivering innovative cancer diagnostic tests to patients and doctors to improve cancer care for all.

Dr. Min-Han Tan

MBBS, FRCP, FAMS, PhD

CEO and Medical Director

Dr. Yukti Choudhury

PhD

Chief Technology Officer

Dr. Pan Zhao

PhD

Chief Commercial Officer

Dr. Min-Han Tan (Han) is the Founder, CEO and Medical Director of Lucence Diagnostics. A trained medical oncologist and clinical cancer geneticist, he received his MBBS in 1998 and PhD in molecular epidemiology and biostatistics in 2011 from the National University of Singapore. He completed his cancer specialist training at the National Cancer Centre Singapore (NCCS). He obtained the Gerber Foundation and Lee Foundation Fellowships to pursue cancer genetics fellowships at the Van Andel Research Institute, Michigan in 2003 and the Cleveland Clinic, Ohio in 2010, respectively. In 2011, He joined the Agency for Science, Technology and Research (A*STAR) in Singapore to lead the Laboratory of Systems Medicine. Han started Lucence in March 2016 to commercialize the genomic technologies that his lab developed at A*STAR.

Han has published over 100 original research publications spanning diverse interests in basic, translational, clinical, public health and policy, and filed more than 12 patents with inventions licensed and deployed in laboratories worldwide. He is recognized internationally for his landmark discovery of circulating tumor-endothelial cell clusters in the blood of cancer patients, which overturned a 50-year scientific dogma. Han also established the international diagnostic criteria and lifetime cancer risks for Cowden syndrome, a hereditary breast cancer syndrome, and led a breast cancer screening research study involving over 29,000 individuals followed up over 20 years.

For his track record of disruptive innovation in research and clinical medicine, Han has been recognized with awards from the American Society of Clinical Oncology, European Society of Medical Oncology and the Association of Southeast Asian Nations. He was elected Fellow of the Royal College of Physicians Edinburgh in 2015 and received the A*STAR Outstanding Scientist-Entrepreneur Award in 2018.

Yukti is the Chief Technology Officer and co-founder of Lucence Diagnostics. A molecular biologist by training, Yukti graduated with a BSc (first class honors) and a PhD from the National University of Singapore. Since university, her research has focused on the development of innovative cancer diagnostics and therapeutics. Prior to joining Lucence, she was a research scientist at the Agency for Science, Technology and Research (A*STAR) in Singapore. Yukti made major breakthroughs by discovering new treatment targets in brain and kidney cancers. Notably, she accomplished the first ever patient-specific, stem cell-based method for modeling drug-induced liver toxicity. She has been recognized for her scientific contributions by the American Society of Clinical Oncology and was named a “Promising Young Investigator” by the Kidney Cancer Association in 2016.  At Lucence, Yukti is responsible for creating new molecular diagnostic technology for cancer detection and treatment. She leads a team of scientists and data professionals who harness the genomic information of patients for better clinical decision-making.

Pan is the Chief Commercial Officer and co-founder of Lucence Diagnostics. She leads the commercialization efforts in bringing our best-in-class cancer diagnostic tests from bench to bedside at Lucence. She is an advocate for precision medicine and genetic testing. Trained as a microbiologist, Pan has been working in the field of molecular diagnostics focusing on oncology and infectious diseases for over 10 years. Prior to Lucence, Pan led the sales and marketing operations for multinational diagnostics companies across the United States, Europe, China and Southeast Asia. She has also successfully developed and commercialized several cutting-edge diagnostic tools and methods. Pan holds a PhD in Microbiology from the National University of Singapore.

Kevin Goh

Chartered Accountant

Chief Financial Officer

Dr. Wai Min Phyo

MBBS, MEng

Director, Assays Development

Jess Vo

BSc (Hons)

Director, Operations

Kevin comes with over 10 years of experience in accounting, assurance and taxation. He oversees the financial planning and infrastructure of the company. His assurance background with KPMG has given him a keen understanding of company growth, compliance needs and project management. In his previous role as the Financial Controller of a listed healthcare company, he developed his skills in operations and workflow management. He is a chartered accountant and holds a Bachelor’s degree in Accountancy from Nanyang Technological University.  Outside of work, Kevin has a keen interest in the game of international chess. He is on the verge of becoming Singapore’s second chess Grandmaster. He is also a seven-time Singapore national chess champion and a globally recognised chess writer.

Wai Min drives assay development and quality at Lucence. Trained in medicine and engineering, he has a track record of successful technology licensing to industry. Prior to Lucence, Wai Min worked at Dr Min-Han Tan’s lab at the Agency for Science, Technology and Research (A*STAR) where he developed novel PCR-based diagnostics that have been commercialized for real-world clinical usage. He was also instrumental in setting up a tissue bank for research and development in colorectal cancer, a collaboration between A*STAR and Fortis Colorectal Hospital. He holds an MBBS from University of Medicine (I), Yangon and a Master’s degree in Engineering from National University of Singapore.

Jess oversees the operational matters and manages key projects at Lucence. She is adept at navigating business growth and operations with her profound understanding of team dynamics. Prior to joining Lucence, she worked in Dr Min-Han Tan’s lab at the Agency for Science, Technology and Research (A*STAR). There, she led and published several key research studies in cancer diagnostics and liquid biopsies. She co-invented a liquid biopsy test that detects early-stage nasopharyngeal cancer which has been commercialised at Lucence. Jess has also been key in the successful filing of new patents at Lucence with her experience in intellectual property management. She graduated with a BSc (Hons) in Biological Sciences from Nanyang Technological University.

Jamen Loh

BEng (Hons)

Country Manager, Hong Kong

Hao Chen

MSc

Director, Informatics

Benson Lim

LLB

General Counsel

Jamen is the country manager of Lucence’s Hong Kong office. He manages all aspects of the operations to effectively deliver our cancer diagnostic services to healthcare providers in Hong Kong. Prior to heading up the Hong Kong office, Jamen was the Director of Marketing at Lucence’s Singapore headquarters. He comes with strong entrepreneurship experience, having started and managed four companies across various industries such as medical logistics, travel, education and events management. This has equipped Jamen with the know-how of building business viability and profitability. He holds a BEng from the National University of Singapore.

Hao creates the core algorithms powering our complex analytics yielding the best possible diagnostic services for our patients. He has an accomplished track record of creating world-class, highly innovative software platforms for analyzing biological and cellular diversity at the Agency for Science, Technology and Research (A*STAR). Regularly ranked among the top downloads on Bioconductor (the primary open-source biological software repository in the world), his algorithms provide insights in high-dimensional and high-throughput single-cell complex data analysis. Hao’s work has been published in top peer-reviewed journals, and he has filed patents on technology for automated and reproducible analysis of complex data. He received his BSc in Biotechnology from the Harbin Institute of Technology (China) and MSc in Bioinformatics from the Nanyang Technology University (Singapore).

As General Counsel at Lucence Diagnostics, Benson oversees the legal aspects of our multi-jurisdictional and rapidly growing businesses. He is called to the Singapore Bar and admitted as a solicitor in England and Wales. He holds a Bachelor of Laws from the National University of Singapore. Benson speaks English and Mandarin Chinese.

Dr. Jack Challis

PhD

Director, Healthcare Analytics, San Francisco

Jessie Qian

CFA, BSc, MSc

Director, Corporate Strategy

Elena Tan

BA

Director, Communications 

As Director of Healthcare Analytics, Jack is responsible for organizing the diverse data streams that empower cancer patients and providers to make the best treatment decisions possible. Based in San Francisco, he also helps Lucence maximize research and commercial opportunities in the United States. An entrepreneur at heart, Jack previously co-founded CliniCast – a startup that helped providers in the US and Singapore organize complex cancer information for research and patient treatment. After Elekta acquired CliniCast in 2015, he helped grow Elekta’s operational analytics portfolio to a global customer base. Jack holds a PhD in Physics from Yale University.

Jessie joins the company with over 13 years of experience as an equity research analyst, portfolio manager, and director of sales at various Wall Street firms. Most recently she served as strategy advisor to the CEO of Genomic Personalized Health, a whole genome sequencing service provider. Her professional background has provided her with a strong foundation in strategic and analytical thinking, as well as effective communication, project management and leadership skills. Jessie is a chartered financial analyst (CFA) and holds a Master’s degree in Management Science from Stanford University Graduate School of Business and a Bachelor’s degree in Finance and Econometrics from University of New South Wales in Sydney. Jessie is also a certified yoga instructor.

Elena has more than 16 years of corporate communications experience in the public and private sectors. She brings significant experience dealing with the medical technology and research sectors to Lucence. Most recently, she was the head of corporate communications at the A*STAR Institute of Bioengineering and Nanotechnology. In that role, she was responsible for external and internal communications for over 150 scientists. She has also held positions in the private sector with Ogilvy Public Relations, GolinHarris, Asurion and Pacific Internet. Elena holds a Bachelor of Arts degree in English Language and Sociology from the National University of Singapore.

Siti Farah Bte Fadhlullah

BSc (Hons)

Laboratory Officer

Yong Herng Low

BSc (Hons)

Laboratory Manager

Melvin Wong

BSc

Deputy Laboratory Manager 

Farah graduated with a BSc (first class honors) in Biological Sciences from Nanyang Technological University. At Lucence, she develops cancer diagnostic assays utilizing advanced sequencing technology. Farah has conducted liquid biopsy research at the Agency for Science, Technology and Research (A*STAR) and brain cancer treatment research at the National Neuroscience Institute (NNI). She has won numerous awards in her early scientific career, including the Promising Young Researcher Award from A*STAR and the Best Junior Research Presentation Award from NNI’s Academic Clinical Program.

Yong Herng oversees laboratory management at Lucence. He played a key role in achieving Lucence’s early milestones of clinical laboratory licensing from the Singapore’s Ministry of Health and ISO 15189 accreditation. Yong Herng joined Lucence from the Singapore General Hospital, where he was a key operator of the External Quality Assurance Program and Safety Program for its biochemistry laboratory. With his background as an underwater combat medic for Singapore’s elite Naval Diving Unit, Yong Herng is skilled in working with highly focused teams to solve complex operational problems. He graduated with a BSc (first class honors) in Medical Bioscience from Aston University.

Melvin is responsible for maintaining adherence to laboratory protocol and test quality control management. Prior to joining Lucence, he was a research officer at the Khoo Teck Puat Hospital for 8 years. There, he contributed significantly to numerous cohort study publications on endocrinology, focusing on Type 2 Diabetes and obesity. Being at the forefront of clinical research, Melvin has gained extensive experience in analytical methods for proteomic biomarker studies. He is also well equipped with next-generation sequencing skills. He holds a BSc in Biomedical Sciences from the University of Western Australia.

Ru Jin Tay

BSc

Genetics Counselor 

Lay Kheng Tan

Dipl in Nursing

Clinic Manager

Joyce Tai

MSc

Research Officer

Ru Jin is a cancer genetics counselor at Lucence’s Genetics Clinic in Singapore. She supports Dr. Min-Han Tan in providing genetic counselling to patients in Singapore and the region. Prior to joining Lucence, Ru Jin was a medical technologist at Singapore General Hospital. She graduated with a BSc in Life Sciences from the National University of Singapore.

Lay Kheng oversees the operations at Lucence’s Genetics Clinic in Singapore. She takes care of the day to day operational matters to ensure the smooth running of the clinic. With her skilled background in nursing and experience caring for patients with genetic disorders of cancer and eyes, she helps to make a positive impact in the lives of our patients. She has a diploma in nursing from Nanyang Polytechnic.

After graduating with a BSc in Biological Sciences from Nanyang Technological University, Joyce ventured into cancer genomics research in circulating tumor cells at the Agency for Science, Technology and Research (A*STAR). She has a keen interest in translational research to bridge findings from the bench to bedside. At Lucence, Joyce is responsible for medical diagnostic testing and helps to maintain workplace health and safety. She holds a MSc in Safety, Health and Environmental Technology from the National University of Singapore.

Marielle Luanzon

Dipl in Molecular Biotechnology

Medical Laboratory Technologist

Hilda Tan

BSc

Account Manager

Marielle is a Medical Laboratory Technologist at Lucence Diagnostics. She processes clinical samples for the various assays offered at Lucence. Prior to Lucence, she was a Medical Technologist at Covance Asia, where she handled patient samples for molecular assays such as DNA and RNA extraction for viral load quantification and genotyping, as well as validation of new instruments and assays. She has also worked at Axil Scientific as a Laboratory Officer for Sequencing, where she focused on the optimization of PCR conditions to deliver higher quality results in a shorter turnaround time. She has a certificate in Basic Industrial Safety and Health Course for Supervisors. Marielle holds a Diploma in Molecular Biotechnology from Nanyang Polytechnic.

Hilda is the Account Manager at Lucence Diagnostics. She is responsible for the management of sales and customer relationships. She has front-line experience in both healthcare and biomedical sectors, which has enabled her to foster good customer relationships with physicians. She graduated with a BSc in Biomedical Sciences from the University of Bradford.

Dr. Daniel Tan Kian Hin

PhD

Clinical Scientist

Dr. Kim Tien Ng

PhD

Scientific Officer

Michelle Tan Bee Kim

BSc (Hons)

Senior Medical Technologist 

Daniel did his postgraduate study in the University of Malaya after the completion of his undergraduate education in the same university. During his postgraduate candidature, he focused on the study of quorum sensing, a form of bacterial communication in an uncommonly studied bacterium, Cedecea neteri. Being driven by his interest in the application of next-generation sequencing (NGS) for clinical research, he joined Lucence Diagnostics. He is now involved in the development and validation of NGS assays.

Kim Tien is the Scientific Officer at Lucence Diagnostics, where his main role includes scaling up robotic process automation to improve operational efficiency, productivity and quality. He holds a PhD in Medical Virology and Molecular Epidemiology from the University of Malaya, during which he developed and patented an improved assay for rhinovirus (RV) quantification. He has received several international Young Scientist Awards in the US, Germany and Japan for his research on the identification and characterization of novel HIV-1 recombinants and the investigation of HIV-1 transmission networks in Southeast Asia. Prior to Lucence, he was a Research Associate at the Duke-NUS Medical School, where he designed the viral and bacterial peptide libraries for potential real-life application in combating disease outbreaks.

Michelle is a Senior Medical Technologist at Lucence Diagnostics. She has extensive experience in genomic testing, particularly in companion diagnostics. Prior to Lucence, she was a medical technologist at the Singapore General Hospital and a contract research organisation. At Lucence, Michelle conducts molecular diagnostic testing on human biological specimens. She has a BSc (Hons) in Biological and Biomedical Sciences from Nanyang Technological University.

Jennifer Ramlan

BSc

Accounts Assistant

Albert Ho Yi Liang

BBA, GDip

Full Stack Engineer

Mai Nguyen

BBA

Head of Rep. Office, Vietnam

Jennifer assists the Chief Financial Officer in accounting and procurement matters at Lucence. She graduated with a BSc in Accounting and Finance (Hons) from the Singapore Management Institute. Jennifer is an avid Yoga practitioner and believes in the conscientious practice of diligence in both life and work.

Yi Liang is responsible for developing an automated workflow management system and data analysis platform at Lucence to enhance the delivery of our cancer diagnostic services. Prior to Lucence, he was a researcher at Nanyang Technological University, where he worked on natural language processing to build next-generation search engines such as ontology search. Yi Liang embraces new technologies like augmented reality, blockchain and Smart Home because he believes that great technology makes life better. He received his BBA from the Harbin Institute of Technology and graduate diploma in Systems Analysis from the National University of Singapore.

Mai Nguyen is responsible for Lucence’s business operations in Vietnam. She has extensive experience in office management, project construction, marketing, and media. Mai’s previous industry touchpoints include office-for-lease and real estate sectors in Vietnam. She holds a Bachelor of Business Administration from Văn Hiến University.

John Yi

BSc

Account Manager

Mai Quach

BEng (Hons)

Medical Laboratory Technologist

Hilary Kan

BSc, MSc

Senior Sales Manager, Hong Kong

Born and raised in Chicago, John graduated from the University of Illinois Urbana-Champaign with a degree in Molecular and Cellular Biology. As Account Manager at Lucence, he handles sales and customer relationships. Prior to joining Lucence, he developed assays for medical devices at Abbot Laboratories in Chicago. With his experience in assay development and understanding of healthcare regulatory requirements, John provides specialized support to physicians to ensure they deliver the best treatment to their patients.

Hilary is the Senior Sales Manager at Lucence’s Hong Kong office. She is responsible for business development to market Lucence’s advanced cancer tests to physicians and healthcare providers. Hilary comes with a strong biotechnology background, particularly in genetic testing. She has extensive sales experience in Hong Kong and Macau as well as international markets like Asia and Europe. She holds a  BSc in Biological Sciences from The University of Hong Kong and a MSc in Marketing from City University of Hong Kong.

Mai joins Lucence after graduating from National University of Singapore with a Bachelor’s degree in Engineering (Biomedical). Her research experience includes developing PCR-based diagnostic assays at A*STAR under its youth research program and designing bioresorbable bone implants for Osteopore International Pte Ltd as a Product Development Intern. Mai has an interest in public health and volunteers regularly for Project X, a non-governmental organization that promotes women’s health in Singapore.

Yangyi Bian

BSc, MSc

Data Scientist

Jack Tang

BSc. Nursing

Senior Sales Manager, Hong Kong

Yangyi is responsible for analytical modelling and data analysis at Lucence. She has strong knowledge of statistics and machine learning, with experience in clinical and imaging data analysis at a hospital. Yangyi holds a Bachelor’s degree in Applied Statistics from Soochow University in China and a Master’s degree in Statistics and Applied Probability from National University of Singapore.

Jack is the Senior Sales Manager at Lucence’s Hong Kong office. She comes with extensive oncology sales experience in the pharmaceutical industry, covering the hospitals and clinics in Hong Kong and Macau. Prior to Lucence, she was a customer liaison manager at Innovative Diagnostics. At Lucence, she is responsible for promoting the adoption of our cancer diagnostic tests among the medical professionals in Hong Kong. Jack has a certificate in Nursing from The Grantham Hospital, Hong Kong.

Dr. Min-Han Tan

MBBS, FRCP, FAMS, PhD

CEO and Medical Director

Dr. Min-Han Tan (Han) is the Founder, CEO and Medical Director of Lucence Diagnostics. A trained medical oncologist and clinical cancer geneticist, he received his MBBS in 1998 and PhD in molecular epidemiology and biostatistics in 2011 from the National University of Singapore. He completed his cancer specialist training at the National Cancer Centre Singapore (NCCS). He obtained the Gerber Foundation and Lee Foundation Fellowships to pursue cancer genetics fellowships at the Van Andel Research Institute, Michigan in 2003 and the Cleveland Clinic, Ohio in 2010, respectively. In 2011, He joined the Agency for Science, Technology and Research (A*STAR) in Singapore to lead the Laboratory of Systems Medicine. Han started Lucence in March 2016 to commercialize the genomic technologies that his lab developed at A*STAR.

Han has published over 100 original research publications spanning diverse interests in basic, translational, clinical, public health and policy, and filed more than 12 patents with inventions licensed and deployed in laboratories worldwide. He is recognized internationally for his landmark discovery of circulating tumor-endothelial cell clusters in the blood of cancer patients, which overturned a 50-year scientific dogma. Han also established the international diagnostic criteria and lifetime cancer risks for Cowden syndrome, a hereditary breast cancer syndrome, and led a breast cancer screening research study involving over 29,000 individuals followed up over 20 years.

For his track record of disruptive innovation in research and clinical medicine, Han has been recognized with awards from the American Society of Clinical Oncology, European Society of Medical Oncology and the Association of Southeast Asian Nations. He was elected Fellow of the Royal College of Physicians Edinburgh in 2015 and received the A*STAR Outstanding Scientist-Entrepreneur Award in 2018.

Dr. Yukti Choudhury

PhD

Chief Technology Officer

Yukti is the Chief Technology Officer and co-founder of Lucence Diagnostics. A molecular biologist by training, Yukti graduated with a BSc (first class honors) and a PhD from the National University of Singapore. Since university, her research has focused on the development of innovative cancer diagnostics and therapeutics. Prior to joining Lucence, she was a research scientist at the Agency for Science, Technology and Research (A*STAR) in Singapore. Yukti made major breakthroughs by discovering new treatment targets in brain and kidney cancers. Notably, she accomplished the first ever patient-specific, stem cell-based method for modeling drug-induced liver toxicity. She has been recognized for her scientific contributions by the American Society of Clinical Oncology and was named a “Promising Young Investigator” by the Kidney Cancer Association in 2016. At Lucence, Yukti is responsible for creating new molecular diagnostic technology for cancer detection and treatment. She leads a team of scientists and data professionals who harness the genomic information of patients for better clinical decision-making.

Dr. Pan Zhao

PhD

Chief Commercial Officer

Pan is the Chief Commercial Officer and co-founder of Lucence Diagnostics. She leads the commercialization efforts in bringing our best-in-class cancer diagnostic tests from bench to bedside at Lucence. She is an advocate for precision medicine and genetic testing. Trained as a microbiologist, Pan has been working in the field of molecular diagnostics focusing on oncology and infectious diseases for over 10 years. Prior to Lucence, Pan led the sales and marketing operations for multinational diagnostics companies across the United States, Europe, China and Southeast Asia. She has also successfully developed and commercialized several cutting-edge diagnostic tools and methods. Pan holds a PhD in Microbiology from the National University of Singapore.

Kevin Goh

Chartered Accountant

Chief Financial Officer

Kevin comes with over 10 years of experience in accounting, assurance and taxation. He oversees the financial planning and infrastructure of the company. His assurance background with KPMG has given him a keen understanding of company growth, compliance needs and project management. In his previous role as the Financial Controller of a listed healthcare company, he developed his skills in operations and workflow management. He is a chartered accountant and holds a Bachelor’s degree in Accountancy from Nanyang Technological University. Outside of work, Kevin has a keen interest in the game of International Chess. He is on the verge of becoming Singapore’s second chess Grandmaster. He is also a seven-time Singapore national chess champion and a globally recognised chess writer.

Dr. Wai Min Phyo

MBBS, MEng

Director, Assays Development

Wai Min drives assay development and quality at Lucence. Trained in medicine and engineering, he has a track record of successful technology licensing to industry. Prior to Lucence, Wai Min worked at Dr Min-Han Tan’s lab at the Agency for Science, Technology and Research (A*STAR) where he developed novel PCR-based diagnostics that have been commercialized for real-world clinical usage. He was also instrumental in setting up a tissue bank for research and development in colorectal cancer, a collaboration between A*STAR and Fortis Colorectal Hospital. He holds an MBBS from University of Medicine (I), Yangon and a Master’s degree in Engineering from National University of Singapore.

Jess Vo

BSc (Hons)

Director, Operations

Jess oversees the operational matters and manages key projects at Lucence. She is adept at navigating business growth and operations with her profound understanding of team dynamics. Prior to joining Lucence, she worked in Dr Min-Han Tan’s lab at the Agency for Science, Technology and Research (A*STAR). There, she led and published several key research studies in cancer diagnostics and liquid biopsies. She co-invented a liquid biopsy test that detects early-stage nasopharyngeal cancer which has been commercialised at Lucence. Jess has also been key in the successful filing of new patents at Lucence with her experience in intellectual property management. She graduated with a BSc (Hons) in Biological Sciences from Nanyang Technological University.

Dr. Jack Challis

PhD

Director, Healthcare Analytics, San Francisco

As Director of Healthcare Analytics, Jack is responsible for organizing the diverse data streams that empower cancer patients and providers to make the best treatment decisions possible. Based in San Francisco, he also helps Lucence maximize research and commercial opportunities in the United States. An entrepreneur at heart, Jack previously co-founded CliniCast – a startup that helped providers in the US and Singapore organize complex cancer information for research and patient treatment. After Elekta acquired CliniCast in 2015, he helped grow Elekta’s operational analytics portfolio to a global customer base. Jack holds a PhD in Physics from Yale University.

Jessie Qian

BSc, MSc

Director, Corporate Strategy

Jessie joins the company with over 13 years of experience as an equity research analyst, portfolio manager, and director of sales at various Wall Street firms. Most recently she served as strategy advisor to the CEO of Genomic Personalized Health, a whole genome sequencing service provider. Her professional background has provided her with a strong foundation in strategic and analytical thinking, as well as effective communication, project management and leadership skills. Jessie is a chartered financial analyst (CFA) and holds a Master’s degree in Management Science from Stanford University Graduate School of Business and a Bachelor’s degree in Finance and Econometrics from University of New South Wales in Sydney. Jessie is also a certified yoga instructor.

Elena Tan

BA

Director, Communications

Elena has more than 16 years of corporate communications experience in the public and private sectors. She brings significant experience dealing with the medical technology and research sectors to Lucence. Most recently, she was the head of corporate communications at the A*STAR Institute of Bioengineering and Nanotechnology. In that role, she was responsible for external and internal communications for over 150 scientists. She has also held positions in the private sector with Ogilvy Public Relations, GolinHarris, Asurion and Pacific Internet. Elena holds a Bachelor of Arts Degree in English Language and Sociology from the National University of Singapore.

Jamen Loh

BEng (Hons)

Country Manager, Hong Kong

Jamen is the country manager of Lucence’s Hong Kong office. He manages all aspects of the operations to effectively deliver our cancer diagnostic services to healthcare providers in Hong Kong. Prior to heading up the Hong Kong office, Jamen was the Director of Marketing at Lucence’s Singapore headquarters. He comes with strong entrepreneurship experience, having started and managed four companies across various industries such as medical logistics, travel, education and events management. This has equipped Jamen with the know-how of building business viability and profitability. He holds a BEng from the National University of Singapore.

Chen Hao

MSc

Director, Informatics

Hao creates the core algorithms powering our complex analytics yielding the best possible diagnostic services for our patients. He has an accomplished track record of creating world-class, highly innovative software platforms for analyzing biological and cellular diversity at the Agency for Science, Technology and Research (A*STAR). Regularly ranked among the top downloads on Bioconductor (the primary open-source biological software repository in the world), his algorithms provide insights in high-dimensional and high-throughput single-cell complex data analysis. Hao’s work has been published in top peer-reviewed journals, and he has filed patents on technology for automated and reproducible analysis of complex data. He received his BSc in Biotechnology from the Harbin Institute of Technology (China) and MSc in Bioinformatics from the Nanyang Technology University (Singapore).

Benson Lim

General Counsel

As General Counsel at Lucence Diagnostics, Benson oversees the legal aspects of our multi-jurisdictional and rapidly growing businesses. He is called to the Singapore Bar and admitted as a solicitor in England and Wales. He holds a Bachelor of Laws from the National University of Singapore. Benson speaks English and Mandarin Chinese.

Yong Herng Low

BSc (Hons)

Laboratory Manager

Yong Herng oversees laboratory management at Lucence. He played a key role in achieving Lucence’s early milestones of clinical laboratory licensing from the Singapore’s Ministry of Health and ISO 15189 accreditation. Yong Herng joined Lucence from the Singapore General Hospital, where he was a key operator of the External Quality Assurance Program and Safety Program for its biochemistry laboratory. With his background as an underwater combat medic for Singapore’s elite Naval Diving Unit, Yong Herng is skilled in working with highly focused teams to solve complex operational problems. He graduated with a BSc (first class honors) in Medical Bioscience from Aston University.

Siti Farah Bte Fadhlullah

BSc (Hons)

Laboratory Officer

Farah graduated with a BSc (first class honors) in Biological Sciences from Nanyang Technological University. At Lucence, she develops cancer diagnostic assays utilizing advanced sequencing technology. Farah has conducted liquid biopsy research at the Agency for Science, Technology and Research (A*STAR) and brain cancer treatment research at the National Neuroscience Institute (NNI). She has won numerous awards in her early scientific career, including the Promising Young Researcher Award from
A*STAR and the Best Junior Research Presentation Award from NNI’s Academic Clinical Program.

Ru Jin Tay

BSc

Genetics Counselor

Ru Jin is a cancer genetics counselor at Lucence’s Genetics Clinic in Singapore. She supports Dr. Min-Han Tan in providing genetic counselling to patients in Singapore and the region. Prior to joining Lucence, Ru Jin was a medical technologist at Singapore General Hospital. She graduated with a BSc in Life Sciences from the National University of Singapore.

Lay Kheng Tan

Dipl. in Nursing

Clinic Manager

Lay Kheng oversees the operations at Lucence’s Genetics Clinic in Singapore. She takes care of the day to day operational matters to ensure the smooth running of the clinic. With her skilled background in nursing and experience caring for patients with genetic disorders of cancer and eyes, she helps to make a positive impact in the lives of our patients. She has a diploma in nursing from Nanyang Polytechnic.

Melvin Wong

BSc (Biomedical)

Deputy Laboratory Manager

Melvin is responsible for maintaining adherence to laboratory protocol and test quality control management. Prior to joining Lucence, he was a research officer at the Khoo Teck Puat Hospital for 8 years. There, he contributed significantly to numerous cohort study publications on endocrinology, focusing on Type 2 Diabetes and obesity. Being at the forefront of clinical research, Melvin has gained extensive experience in analytical methods for proteomic biomarker studies. He is also well equipped with next-generation sequencing skills. He holds a BSc in Biomedical Sciences from the University of Western Australia.

HIlda Tan

BSc (Biomedical)

Accounts Manager

Hilda is the Account Manager at Lucence Diagnostics. She is responsible for the management of sales and customer relationships. She has front-line experience in both healthcare and biomedical sectors, which has enabled her to foster good customer relationships with physicians. She graduated with a BSc in Biomedical Sciences from the University of Bradford.

Jennifer Ramlan

BSc

Account Assistant

Jennifer assists the Chief Financial Officer in accounting and procurement matters at Lucence. She graduated with a BSc in Accounting and Finance (Hons) from the Singapore Management Institute. Jennifer is an avid Yoga practitioner and believes in the conscientious practice of diligence in both life and work.

Dr. Daniel Tan Kian Hin

PhD

Clinical Scientist

Daniel did his postgraduate study in the University of Malaya after the completion of his undergraduate education in the same university. During his postgraduate candidature, he focused on the study of quorum sensing, a form of bacterial communication in an uncommonly studied bacterium, Cedecea neteri. Being driven by his interest in the application of next-generation sequencing (NGS) for clinical research, he joined Lucence Diagnostics. He is now involved in the development and validation of NGS assays.

Dr. Kim Tien Ng

PhD

Scientific Officer

Kim Tien is the Scientific Officer at Lucence Diagnostics, where his main role includes scaling up robotic process automation to improve operational efficiency, productivity and quality. He holds a PhD in Medical Virology and Molecular Epidemiology from the University of Malaya, during which he developed and patented an improved assay for rhinovirus (RV) quantification. He has received several international Young Scientist Awards in the US, Germany and Japan for his research on the identification and characterization of novel HIV-1 recombinants and the investigation of HIV-1 transmission networks in Southeast Asia. Prior to Lucence, he was a Research Associate at the Duke-NUS Medical School, where he designed the viral and bacterial peptide libraries for potential real-life application in combating disease outbreaks.

Dr. Kelly Quek

PhD

Clinical Genomic Scientist

Michelle Tan Bee Kim

BSc (Hons)

Senior Medical Technologist

Michelle is a Senior Medical Technologist at Lucence Diagnostics. With her Hospital background and extensive experience in a Contract Research Organisation, Michelle is equipped with knowledge in both Automation and Genomics testing, with a focus on Companion Diagnostics. At Lucence, Michelle’s expertise contributes significantly to the growing needs of physicians for accurate and quality results. Apart from her laboratory work, Michelle can be found spending quality time with her young daughter and two lovely guinea pigs.

Mai Nguyen

BBA

Head of Rep. Office Vietnam

Mai Nguyen is responsible for Lucence’s business operations in Vietnam. She has extensive experience in office management, project construction, marketing, and media. Mai’s previous industry touchpoints include office-for-lease and real estate sectors in Vietnam. She holds a Bachelor of Business Administration from Văn Hiến University.

John Yi

BSc

Account Manager

Born and raised in Chicago, John graduated from the University of Illinois Urbana-Champaign with a degree in Molecular and Cellular Biology. As Account Manager at Lucence, he handles sales and customer relationships. Prior to joining Lucence, he developed assays for medical devices at Abbot Laboratories in Chicago. With his experience in assay development and understanding of healthcare regulatory requirements, John provides specialized support to physicians to ensure they deliver the best treatment to their patients.

Albert Ho Yiliang

BSc, GDip

Full Stack Engineer

Yi Liang is responsible for developing an automated workflow management system and data analysis platform at Lucence to enhance the delivery of our cancer diagnostic services. Prior to Lucence, he was a researcher at Nanyang Technological University, where he worked on natural language processing to build next-generation search engines such as ontology search. Yi Liang embraces new technologies like augmented reality, blockchain and Smart Home because he believes that great technology makes life better. He received his BBA from the Harbin Institute of Technology and graduate diploma in Systems Analysis from the National University of Singapore.”

Hilary Kan

BSc, MSc

Senior Sales Manager, Hong Kong

Hilary is the Senior Sales Manager at Lucence’s Hong Kong office. She is responsible for business development to market Lucence’s advanced cancer tests to physicians and healthcare providers. Hilary comes with a strong biotechnology background, particularly in genetic testing. She has extensive sales experience in Hong Kong and Macau as well as international markets like Asia and Europe. She holds a BSc in Biological Sciences from The University of Hong Kong and a MSc in Marketing from City University of Hong Kong.

Joyce Tai

MSc

Research Officer

After graduating with a BSc in Biological Sciences from Nanyang Technological University, Joyce ventured into cancer genomics research in circulating tumor cells at the Agency for Science, Technology and Research (A*STAR). She has a keen interest in translational research to bridge findings from the bench to bedside. At Lucence, Joyce is responsible for medical diagnostic testing and helps to maintain workplace health and safety. She holds a MSc in Safety, Health and Environmental Technology from the National University of Singapore.

Marielle Luanzon

Dipl in Molecular Biotechnology

Medical Laboratory Technologist

Marielle is a Medical Laboratory Technologist at Lucence Diagnostics. She processes clinical samples for the various assays offered at Lucence. Prior to Lucence, she was a Medical Technologist at Covance Asia, where she handled patient samples for molecular assays such as DNA and RNA extraction for viral load quantification and genotyping, as well as validation of new instruments and assays. She has also worked at Axil Scientific as a Laboratory Officer for Sequencing, where she focused on the optimization of PCR conditions to deliver higher quality results in a shorter turnaround time. She has a certificate in Basic Industrial Safety and Health Course for Supervisors. Marielle holds a Diploma in Molecular Biotechnology from Nanyang Polytechnic.

Mai Quach

BEng (Hons)

Medical Laboratory Technologist

Mai joins Lucence after graduating from National University of Singapore with a Bachelor’s degree in Engineering (Biomedical). Her research experience includes developing PCR-based diagnostic assays at A*STAR under its youth research program and designing bioresorbable bone implants for Osteopore International Pte Ltd as a Product Development Intern. Mai has an interest in public health and volunteers regularly for Project X, a non-governmental organization that promotes women’s health in Singapore.

Yangyi Bian

BSc, MSc

Data Scientist

Yangyi is responsible for analytical modelling and data analysis at Lucence. She has strong knowledge of statistics and machine learning, with experience in clinical and imaging data analysis at a hospital. Yangyi holds a Bachelor’s degree in Applied Statistics from Soochow University in China and a Master’s degree in Statistics and Applied Probability from National University of Singapore.

Jack Tang

BSc. Nursing

Senior Sales Manager, Hong Kong

Jack is the Senior Sales Manager at Lucence’s Hong Kong office. She comes with extensive oncology sales experience in the pharmaceutical industry, covering the hospitals and clinics in Hong Kong and Macau. Prior to Lucence, she was a customer liaison manager at Innovative Diagnostics. At Lucence, she is responsible for promoting the adoption of our cancer diagnostic tests among the medical professionals in Hong Kong. Jack has a certificate in Nursing from The Grantham Hospital, Hong Kong.

You

“We see the fight against cancer as a mission. If we can deliver top quality diagnostics and screening for all cancers at the early stages, that is something worth our time, energy and everything.”
– Dr. Min-Han Tan, CEO and Medical Director, Lucence Diagnostics

“We see the fight against cancer as a mission. If we can deliver top quality diagnostics and screening for all cancers at the early stages, that is something worth our time, energy and everything.”

– Dr. Min-Han Tan, CEO and Medical Director, Lucence Diagnostics

LUCENCE PARTNERS

We are a venture-backed medical technology company with the mission to fight cancer by detecting the disease earlier and saving lives earlier. On this journey, we’ve assembled a team of like-minded investors with an understanding of how great technology is grown, how it can improve lives and reduce suffering for humanity.

 

If you share our vision and want to come aboard as a partner, don’t hesitate to reach out to us for more information.

LUCENCE PARTNERS

We are a venture-backed medical technology company with the mission to fight cancer by detecting the disease earlier and saving lives earlier. On this journey, we’ve assembled a team of like-minded investors with an understanding of how great technology is grown, how it can improve lives and reduce suffering for humanity.

 

If you share our vision and want to come aboard as a partner, don’t hesitate to reach out to us for more information.